Endocan reduces the malign grade of gastric cancer cells by regulating associated protein expression

In conclusion, our findings suggest that endocan plays an anti-carcinogenic role in gastric cancer development and progression and might serve as a prognostic biomarker as well as a potential therapeutic target for gastric cancer.
Source: Tumor Biology - Category: Cancer & Oncology Source Type: research